-+ 0.00%
-+ 0.00%
-+ 0.00%

CELULARITY ANNOUNCES PEER-REVIEWED PUBLICATION OF PHASE 2 CLINICAL TRIAL RESULTS DEMONSTRATING THE SAFETY AND EFFICACY OF HUMAN PLACENTA-DERIVED CELLS (PDA-002) FOR DIABETIC FOOT ULCERS COMPLICATED BY PERIPHERAL ARTERY DISEASE

Reuters·10/14/2025 12:45:00

Please log in to view news